RMS regrow get FDA India approval for Cell Therapy Product
- Regeneration of cartilage instead of replacing your entire knee
- Minimally invasive personalized treatment
- Increased quality of life
- Resume complete physical activity , including of professional sports
- Cost Effective
- Joint preservation providing Long term relief
Chondron ACI is recommended for patients of 15-65 years age group. It is imperative for a patient to go through rehabilitation process for a minimum of six weeks. The rehabilitation process is performed in the guidance of the doctor and the physiotherapist. There is also medical insurance reimbursement available with Chondron ACI.
In India, Osteoarthritis is the most prevalent form of arthritis, affecting over 15 million adults every year. There is no specific treatment proven as yet that can reverse the joint damage caused by osteoarthritis. Hence the objectives of Osteoarthritis management are to reduce the level of pain, reduce inflammation, slow cartilage degradation, improve function and reduce disability.
There are about 4-5 lakhs of knee, ankle, shoulder and hip replacement revision surgeries being performed in India annually and the number is only going up every year. An artificial knee will only last about a decade before wearing out. So if you are under 60, you will have to undergo several more ‘revisions’ in your lifetime. Chondron ACI helps for better solution with effective and fast term results. Similar nature products for Chondron ACI have been available in use since 2001 in countries such as USA, Europe including UK & South Korea and being reimbursed by their respective Health agencies.